Business Context and Reporting Period
This Form 8-K is a current report filed by ChromaDex Corporation (not Niagen Bioscience, Inc.) on July 13, 2015, covering events that occurred on July 9, 2015. The filing addresses changes to the Company's Board of Directors.
Key Financial Metrics
This filing is a current report regarding corporate governance and does not contain financial statements. Consequently, there are no reported values for revenue, profit, cash flow, margins, debt, or liquidity in this document.
Material Changes
- Board Appointment: Robert Fried was appointed to the Board of Directors and the Nominating and Corporate Governance Committee.
- Board Resignation: Glenn Halpryn resigned from the Board of Directors.
- Reason for Resignation: The filing explicitly states Mr. Halpryn's resignation was not the result of any disagreements with the Company's operations, policies, or practices.
Management Commentary and Risks
The filing includes a detailed biography of the new appointee, Robert Fried, highlighting his extensive experience in media, digital business, and film production, including roles at Hallmark Cards Inc., IDI, Inc., and as an Academy Award-winning producer. No specific financial risks, contingencies, or unusual items were disclosed in this report.
Investor Verification Checklist
- Verify the updated composition of the Board of Directors on the Company's investor relations website.
- Review the attached press release (Exhibit 99.1) for additional context on the strategic rationale for the board changes.
- Confirm that no other undisclosed disagreements exist regarding the departing director by reviewing subsequent filings.
- Note that this filing contains no financial data; refer to the most recent 10-Q or 10-K for financial performance metrics.